Related references
Note: Only part of the references are listed.Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data
Samuel Mon-Wei Yu et al.
JOURNAL OF NEPHROLOGY (2021)
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J. M. van Bommel et al.
KIDNEY INTERNATIONAL (2020)
SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
Megan Leila Baker et al.
JOURNAL OF NEPHROLOGY (2020)
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
Dario Giugliano et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors
Milton Packer
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Association Between Plant and Animal Protein Intake and Overall and Cause-Specific Mortality
Jiaqi Huang et al.
JAMA INTERNAL MEDICINE (2020)
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z I Cherney et al.
Lancet Diabetes & Endocrinology (2020)
Nephroprotection by SGLT2 Inhibition: Back to the Future?
Luca De Nicola et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Nutritional management of kidney diseases: an unmet need in patient care
Adamasco Cupisti et al.
JOURNAL OF NEPHROLOGY (2020)
Plant-based diets, insulin sensitivity and inflammation in elderly men with chronic kidney disease
Ailema Gonzalez-Ortiz et al.
JOURNAL OF NEPHROLOGY (2020)
Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
D. V. O'Hara et al.
JOURNAL OF NEPHROLOGY (2020)
FOREWORD
Alison Steiber et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
Michele Provenzano et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Association of sulfur amino acid consumption with cardiometabolic risk factors: Cross-sectional findings from NHANES III
Zhen Dong et al.
ECLINICALMEDICINE (2020)
The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD
Laetitia Koppe et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017
Kazuhiro Hasegawa
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
Kengo Kidokoro et al.
CIRCULATION (2019)
Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider
Aleix Cases et al.
NUTRIENTS (2019)
Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality in a Japanese Cohort
Sanjeev Budhathoki et al.
JAMA INTERNAL MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy
Sonia Sifuentes-Franco et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
David Z. I. Cherney et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study
Anna Solini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?
Harindra Rajasekeran et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Urinary adenosine excretion in type 1 diabetes
Harindra Rajasekeran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES CARE (2017)
Diet and Diabetic Kidney Disease: Plant Versus Animal Protein
Ranjani N. Moorthi et al.
CURRENT DIABETES REPORTS (2017)
A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity
Munehiro Kitada et al.
DIABETOLOGIA (2016)
Dietary Protein as Kidney Protection: Quality or Quantity?
Nimrit Goraya et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The NLRP3 inflammasome in kidney disease and autoimmunity
Holly L. Hutton et al.
NEPHROLOGY (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Autophagy in diabetic nephropathy
Yan Ding et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Hypoxia signaling pathways: modulators of oxygen-related organelles
Miriam J. Schonenberger et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data
Massimo Cirillo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors
John P. H. Wilding
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Amino acid signalling upstream of mTOR
Jenna L. Jewell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial
Kelsey M. Mangano et al.
NUTRITION RESEARCH (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
The Acetylase/Deacetylase Couple CREB-binding Protein/Sirtuin 1 Controls Hypoxia-inducible Factor 2 Signaling
Rui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Forty Percent Methionine Restriction Decreases Mitochondrial Oxygen Radical Production and Leak at Complex I During Forward Electron Flow and Lowers Oxidative Damage to Proteins and Mitochondrial DNA in Rat Kidney and Brain Mitochondria
Pilar Caro et al.
REJUVENATION RESEARCH (2009)
Effects of soy protein hydrolysate on blood pressure and angiotensin-converting enzyme activity in rats with chronic renal failure
Hsin-Yi Yang et al.
HYPERTENSION RESEARCH (2008)
Ca2+ channel subtypes and pharmacology in the kidney
Koichi Hayashi et al.
CIRCULATION RESEARCH (2007)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy
SR Teixeira et al.
JOURNAL OF NUTRITION (2004)
High-protein diets: Potential effects on the kidney in renal health and disease
AN Friedman
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)